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1. INTRODUCTION {#hex12814-sec-0006}
===============

Enabling patient and public involvement (PPI) in health services research is now a prerequisite.[1](#hex12814-bib-0001){ref-type="ref"}, [2](#hex12814-bib-0002){ref-type="ref"}, [3](#hex12814-bib-0003){ref-type="ref"}, [4](#hex12814-bib-0004){ref-type="ref"} Two of us have theorized PPI as "knowledge spaces," that is spaces where expert knowledge and forms of lay knowledge can interact with each other on an equal basis.[5](#hex12814-bib-0005){ref-type="ref"} In this paper, we trace out how the interaction between different forms of knowledge works in practice drawing on an example of PPI in qualitative data analysis to illustrate our points. Our analysis of the process has led us to conceptualize this interaction as a dialectical one, operating between lay and academic perspectives.

Previous work has indicated that PPI has a role in qualitative data analysis (QDA). It can correct researchers' misinterpretations and challenge the ways in which findings are reported,[6](#hex12814-bib-0006){ref-type="ref"}, [7](#hex12814-bib-0007){ref-type="ref"} and add value to the products of research analysis.[8](#hex12814-bib-0008){ref-type="ref"} While qualitative methods to augment clinical trials are mainstream,[9](#hex12814-bib-0009){ref-type="ref"} the role of PPI is often overlooked.[10](#hex12814-bib-0010){ref-type="ref"}, [11](#hex12814-bib-0011){ref-type="ref"} Where PPI representatives have been involved in QDA alongside clinical trials, the impact of such involvement is often unclear.[12](#hex12814-bib-0012){ref-type="ref"}

Examples of PPI in QDA as explicit emancipatory practice, sometimes described as community‐based participatory research (CBPR),[13](#hex12814-bib-0013){ref-type="ref"} are prevalent in sociological research and achieved by tailoring how data are presented, engaged with, managed and categorized. Working with disadvantaged women, Jackson[14](#hex12814-bib-0014){ref-type="ref"} provided facilitation alongside simplified instructions and processes, such as encouraging participants to summarize data in lay language. Conducting analysis with people with learning disabilities, Nind[15](#hex12814-bib-0015){ref-type="ref"} recommended tailoring approaches to local contexts, with academics variously taking on the role of "trainer, coach, scaffolder, mentor, partner in dialogue, co‐learner, reciprocal learner and practical facilitator." Kaomea[16](#hex12814-bib-0016){ref-type="ref"} has also shown that indigenous participants work with a different set of perspectives and tools when undertaking analysis, which may challenge taken for granted research practices, allowing findings to be challenged and re‐examined.

The underpinning philosophies of CBPR and PPI are commensurate, with both valuing meaningful partnership and collaboration to achieve change in the conduct and products of research.[17](#hex12814-bib-0017){ref-type="ref"} We, academic co‐authors JF, AG, and NB, also drew on the literature about critical humility and participatory research to guide our conduct.[13](#hex12814-bib-0013){ref-type="ref"}, [18](#hex12814-bib-0018){ref-type="ref"} Emancipatory practices can be fostered by researchers' "critical humility," or lifelong commitment to self‐evaluation and critique, as lifelong learners and reflective practitioners.[18](#hex12814-bib-0018){ref-type="ref"} The political imperative is to subvert or challenge the status quo (here the canon of accepted research methods and practices), with the objective of enabling those who are traditionally the focus of studies (e.g. "patients") to understand their world in order to transform it---a form of "catalytic validity".[19](#hex12814-bib-0019){ref-type="ref"} Although Lather[20](#hex12814-bib-0020){ref-type="ref"} proposed that catalytic validity needs to be consciously designed into the research process in order to democratize knowledge, Baines[21](#hex12814-bib-0021){ref-type="ref"} contends that facilitating meaningful PPI contributions to knowledge would require a shift in the political economy of universities and research funders. Furthermore, the selectivity with which PPI representatives are chosen (reifying some voices to the detriment of others) has also been questioned.[22](#hex12814-bib-0022){ref-type="ref"}, [23](#hex12814-bib-0023){ref-type="ref"} However, this situation is beginning to change.[24](#hex12814-bib-0024){ref-type="ref"}, [25](#hex12814-bib-0025){ref-type="ref"}

In this study, as the aim was to ensure that patients' concerns were addressed in the consultation, a correspondingly emancipatory approach to the data analysis required patients' perspectives to inform the data analysis. Crucially, analytic judgements about whether the intervention had indeed facilitated the discussions of patients' concerns should be informed by patient perspectives. Conventionally, these judgements have been made by academic researchers alone.[26](#hex12814-bib-0026){ref-type="ref"}

1.1. Diabetes Intervention for Agenda Trial (DIAT) {#hex12814-sec-0007}
--------------------------------------------------

We conducted a pilot study of a pre‐consultation intervention in which patients were supported by health‐care assistants (HCAs) to complete a Web‐based intervention to facilitate the production of "their own agenda" for discussion in a consultation with their diabetologists (Diabetes Intervention for Agenda Trial (DIAT);[27](#hex12814-bib-0027){ref-type="ref"}, [28](#hex12814-bib-0028){ref-type="ref"}). By combining trial and qualitative methods, we sought to identify how the intervention influenced consultations, and decide whether proceeding to a full trial was appropriate.

Patients were involved at all stages, in order to increase the probability that the intervention would be adopted in practice.[29](#hex12814-bib-0029){ref-type="ref"} The research question was generated from a prioritization exercise, undertaken by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care in the South West Peninsula (PenCLAHRC) with active involvement from the Peninsula Patient and Public Involvement Group (PenPIG). People with diabetes (including PPI representative 1 or "PPI1") suggested that outpatient clinic appointments are pressured times, where health professionals can overlook issues that are worrying patients or where patients can feel inhibited from voicing their concerns. Supported by a PPI Research Fellow (AG), two members of PenPIG (FH‐G and JH) who have diabetes joined the research team as funding co‐applicants and members of the project management team. They co‐wrote the study documentation, assisted with training the HCAs to deliver the pre‐consultation intervention, participated in the data analysis and disseminated preliminary findings. Eight additional people with diabetes, recruited from the NIHR Diabetes Research Network and Diabetes UK, provided feedback on an early iteration of the intervention, and another participated in the trial steering group. With 4 other members of PenPIG, the two co‐applicants ("PPI2" and "PPI3") participated in a PPI qualitative data analysis group ("PPI group" with R denoting Researcher).

Seventy‐one patients were randomized to either the intervention or usual care.[26](#hex12814-bib-0026){ref-type="ref"} With participants' and diabetologists' consent, we audio‐recorded intervention sessions and clinical consultations, to explore how participants generated and utilized the intervention. Thirteen patients randomized to receive the intervention consented to be recorded and twelve had both an intervention session and a consultation recorded, while one had only their consultation recorded. Twelve control patients consented and had a "usual" consultation recorded. Recording consultations facilitated our understanding of the impact of the production of an agenda on the clinical consultation, and its subsequent use in practice when compared with usual care.[24](#hex12814-bib-0024){ref-type="ref"}, [30](#hex12814-bib-0030){ref-type="ref"} Author A conducted 12 semi‐structured interviews with a convenience sample of participating staff and 12 patients (6 in each trial arm) to explore wider organizational factors. Interview questions were based upon the existing literature and PPI perspectives and aimed to capture staff and patient experience of diabetes consultations and the intervention specifically. Data were transcribed verbatim, anonymized and managed using Nvivo software. Preliminary framework analysis[31](#hex12814-bib-0031){ref-type="ref"} facilitated deductive and inductive analysis, enabling the exploration of the role of the intervention and trial processes alongside the elicitation of patient, provider and PPI perspectives.

Qualitative data analysis began with JF and a diabetes specialist nurse (DSN) co‐applicant independently familiarizing themselves with the first 20 consultations.[32](#hex12814-bib-0032){ref-type="ref"} In the control arm, we explored the *usual* consultation style of each participating diabetologist. In the intervention arm, we explored the extent to which diabetologist used the agenda form as a guide for the consultation. A preliminary charting exercise (Table [1](#hex12814-tbl-0001){ref-type="table"}) allowed us to identify relationships between the process of agenda identification and agenda use.[23](#hex12814-bib-0023){ref-type="ref"} Thus JF and the DSN co‐applicant identified a preliminary typology of consultations (patient ignored, diabetologist led, patient led, diabetologist and patient led).

###### 

Extract from preliminary charting exercise

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Demographic data              Intervention                                                                                                                                                                                                                                                                                                                                                                       Agenda form                                                                                                                                                          Consultation
  ----------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient: XXXX\                F provided information and support as per training.\                                                                                                                                                                                                                                                                                                                               *Particular concern:* "my blood sugar levels are always high i find that emotions play a big part in raising these levels can I increase the dosage of exenatide"\   No initial discussion of agenda form.\
  Diabetologist: XX\            P struggles to read the screen. Needed text enlarged and moved chair closer.\                                                                                                                                                                                                                                                                                                      *Concern about diabetes:* "there are so many ways it alters your there are too many to mention"\                                                                     D begins by identifying P on his records and checking which medication P is taking. P is slightly confused, and D says: 'I suppose one thing this illustrates is really useful if you can bring a copy of your prescription with you.'\
  Allocation: *Intervention*\   P volunteers that he has problems with spelling 'I suffer from...I can\'t spell, so', and F spells out 'blood sugar'...\                                                                                                                                                                                                                                                           *Concern about medication: "*can i increase exenatide what good will it do how much should i increase the insulin dose by to lower the sugar levels"\                P says that he recently had a heart attack, but D cannot find a record of relevant blood tests, and D asks P if he is 'quite sure' of when he was in hospital.\
  Facilitator: XX\              \[long pause\]\                                                                                                                                                                                                                                                                                                                                                                    *Concern about managing diabetes:* "diet"                                                                                                                            D says that a recent HbA1c result 'wasn\'t very good' and P admits that he has been struggling with self‐monitoring, and has been having high results, which he attributes to stress about his sisters illness.\
  Age: XX\                      P: "Last time, no, the time before, I saw \[Consultant\]. At the end of the consultation he said to me, erm, 'you have 10 seconds is there anything else you would like to ask me' which I thought was, you know, ha ha ha...couldn\'t believe it, I was so gob smacked... I just walked out you know...Well he seemed very arrogant to me... Can I make a comment on it here?"\                                                                                                                                                                        D then refers to the agenda form: "Okay now you have got this list of questions here for the study and the first thing you ask is my blood sugar levels are always high I find the emotions play a big part in raising these levels. Can I increase the dose of Exenatide? The answer to that last question is no, you can\'t." There is a lengthy discussion re: Exenatide, with D proposing other medications to control HbA1c, and P suggesting that D has not got his dose correct
  Gender: X\                    F reiterates that P can write what he wants, but he does not make this comment.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Date: xx.xx.xx                Ps concerns would 'take pages' because he has 'any number of them' --- he says that he is 'not trying to be facetious' and 'asks 'how long have I got?' as his diabetes has such an impact: 'Physically can\'t do what I used to do... I can\'t eat what I used to do I can\'t drink...I can\'t...It completely alters your way of life, you know.'                                                                                                                                                                                                     

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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The aims of this study were to describe a novel approach to involving patient partners in QDA; to illustrate the kinds of contribution that patient partners made to QDA; and to propose a characterization of a process by which patient involvement can contribute to knowledge production.

2. METHODS {#hex12814-sec-0008}
==========

2.1. Training {#hex12814-sec-0009}
-------------

JF, AG, and NB trained a group of six PPI representatives (the PPI group, including co‐applicants PPI2 and PPI3), in QDA techniques (such as paying attention to nuances in consultations, and constructing patterns within and across consultations[32](#hex12814-bib-0032){ref-type="ref"}) during three workshops. During the workshops, the PPI group had access to verbatim transcripts of consultations and in‐depth interviews, but data governance considerations meant that data access was confined to the workshop. The PPI group did not listen to the audio‐recordings of the transcripts directly, to maintain confidentiality. JF and AG therefore role‐played the anonymized consultations from the charting exercise, making sure that they captured the audible nuances of the audiotape, and provided vignettes which summarized the "cases." Role‐play provides insight into social interaction and can provide a stimulus for discussion.[33](#hex12814-bib-0033){ref-type="ref"} Vignettes are stories about individuals, situations and structures, which allow actions to be explored in context and provide a less personal means of exploring sensitive topics.[34](#hex12814-bib-0034){ref-type="ref"}

In *Workshop 1* (3 hours), the researchers introduced the study to the PPI group members who were unfamiliar with the project and the aims of the workshops. They described data collection and preliminary analysis to date. Large data matrices were used to demonstrate how the researchers had conducted their preliminary coding, and participants were given instructions as to how they might produce their own codes about "what is going on" and "whose agenda is dominant" from the data that they would be given. The researchers then provided the PPI group with a vignette (Patient 1---Figure [1](#hex12814-fig-0001){ref-type="fig"}) and asked them to read the transcript and observe a role‐play of a consultation in the usual care arm of the trial. PPI participants were then provided with the researchers' preliminary typology, as a stimulus to develop their own codes. The researchers had produced a form to guide participants in conducting their analysis, but this was felt by the group to be too constraining. Instead, "codes" were identified from line‐by‐line discussion of the transcript. These analytical discussions were captured by the researchers using a flip chart. The skilled PPI facilitator summarized PPI discussions and probed further for clarification. Notes of these discussions informed revisions to the preliminary coding frame, which, in turn, were fed back to the PPI group and shaped their subsequent analysis.

![Illustrative vignettes](HEX-21-1111-g001){#hex12814-fig-0001}

In *Workshop 2* (6 hours), role‐play was used to portray a consultation in the intervention arm of the trial (Patient 2---Figure [1](#hex12814-fig-0001){ref-type="fig"}) and a subsequent qualitative interview in which the participant discussed his experience, alongside a contextual vignette. The PPI group read and discussed transcripts from both the consultation and interview, and were asked to critique and develop the typology. In *Workshop 3* (2 hours), the PPI group was provided with their revised typology, with the codes that they had identified, supported with descriptors from the previous discussions. They were given 4 further vignettes from a purposive sample of the consultation data. In small groups, participants led the analytical discussions, testing the codes and descriptors against the data, in the same way that teams of qualitative researchers conduct analytical discussions.

Thus, over the course of three workshops, and using a hands‐on approach, the researchers and the PPI group went through the key stages of framework analysis, consisting of familiarization with the data, coding, developing an analytical framework, applying the framework, charting and interpreting the data.[31](#hex12814-bib-0031){ref-type="ref"}, [33](#hex12814-bib-0033){ref-type="ref"}

2.2. Data collection {#hex12814-sec-0010}
--------------------

The 2 PPI co‐applicants (PPI2 and PPI3) kept diaries and included information which they felt comfortable sharing with the wider research team.[35](#hex12814-bib-0035){ref-type="ref"} Repeat semi‐structured interviews (2 qualitative interviews, one in each year of the project, with each of the two co‐applicants), conducted by the PPI facilitator (AG), elaborated upon the reflections captured in the diaries and changes in experience over time.[36](#hex12814-bib-0036){ref-type="ref"} PPI co‐applicants were asked about their experience of participation, their identification of barriers and facilitators to participation, and their perceptions of the value that their contribution made to the research. The QDA workshops were audio‐recorded. Ethical approval for the original proposal and subsequent amendments was granted by the NHS Research Ethics Committee North West---Preston (13/NW/0123). The 2 PPI co‐applicants provided written consent for their diaries and interviews to be analysed. As the group\'s PPI analysis was a PPI activity to shape research, NHS REC approval was not required.

2.3. Data analysis {#hex12814-sec-0011}
------------------

Thematic discourse analysis was developed over the course of 3 workshops using all sources of data, paying attention to micro‐level discourse and the construction of the meaning of involvement to illustrate the cumulative process of knowledge production in a knowledge space[31](#hex12814-bib-0031){ref-type="ref"}, [32](#hex12814-bib-0032){ref-type="ref"} by Authors JF, AG, and NB, with further clarification from FH‐G and JH. The results of each workshop are presented in turn, reflecting our analysis at both a workshop and cumulative level, and our objective of assessing the contribution of PPI to the process of QDA.

3. RESULTS {#hex12814-sec-0012}
==========

3.1. Workshop 1: Hypothesis testing {#hex12814-sec-0013}
-----------------------------------

By providing the PPI group with a preliminary typology, the academic co‐authors were demonstrating an analytical process without suggesting that the PPI group should validate those suggestions.[37](#hex12814-bib-0037){ref-type="ref"} In terms of the critical humility of the researchers, and recognizing that our preliminary analyses were led by our own assumptions, we saw this as part of a conversation in which we were opening ourselves up to their experiential knowledge and interpretations as one would with other research and clinical partners.[38](#hex12814-bib-0038){ref-type="ref"} The PPI group subsequently developed the preliminary typology by proposing the terms "*patient identified*" (rather than "*patient led*") and "*diabetologist facilitated"* (rather than *"diabetologist led"*) as more nuanced, with subsequent rich discussions forming coding descriptors. With regard to "*patient ignored*," the PPI group were able to describe the challenge of voicing the patients' agenda in usual care by referencing what was different in the intervention consultations:PPI2In the \[example from usual care\], I would have been on my own; I was well *left*, you know, I was not part of it at all. This \[example from intervention arm\] I think he was joining in, he was involved, he was led a bit, but he was saying 'Yes', so he was obviously led in the right direction. (Extract 1)

Similarly, a *"diabetologist facilitated"* style was identified in both trial arms; such that a diabetologist\'s particular practice could both pre‐date and be enhanced by the use of an agenda form:PPI4In the control arm, having a consultant who typically has a facilitative style \[without agenda form\] e.g. \[Patient from control arm\] talks about erectile dysfunction comfortably with the same consultant that \[Patient from intervention arm\] does. (Extract 2)

By comparing the interview data with the consultation data, the PPI group were able to discern aspects that the "*patients identified"* (e.g. wrote down on the agenda form without the need to vocalize sensitive matters), and which patients later discussed in an interview:PPI5Yeah, I think the consultant did quite a good job really, and I think he also handled talking about erectile dysfunction \[item on agenda form which patient did not articulate\] very sympathetically and very, you know¸ sort of a way that perhaps hopefully was comfortable with the patient, too, which is, you know, sometimes, I think things like that are handled very poorly. (Extract 3)

Finally, the PPI group discussed what constituted a "*patient identified and diabetologist facilitated"* agenda:PPI6I think, yeah, the doctor brought his agenda into play but he interweaved it into the patient\'s agenda. He fed in at the important places with his stuff. (Extract 4)

These newly identified codes and descriptors were then used by the research team to further analyse the data and develop display matrices for each category:Diabetologist facilitatedRather than seeing the consultations as '*Diabetologist led'* (implicitly paternalistic), the PPI group recognised and described a consultative style that was facilitative. This could occur in the usual care arm of the study, where an agenda form was not produced, but when a diabetologists skilfully elicited the patient\'s concerns. Patient identified (intervention arm)Rather than assuming that the agenda form in the intervention arm would empower the patient (implicitly beneficial), the PPI group explained that it was sufficient and appropriate for the patient to produce an agenda to convey their concerns, with the diabetologists subsequently leading the consultation.

These nuanced codes are in keeping with the findings of Cribb et al[39](#hex12814-bib-0039){ref-type="ref"} who suggest that broader conceptions of shared decision‐making allow for open‐ended and fully dialogic ways of relating. These new codes were then applied to the whole data set and complete matrices discussed again with the PPI group.

3.2. Workshop 2: Challenging {#hex12814-sec-0014}
----------------------------

Here, we explore one of the coding discussions ("*patient identified and diabetologist facilitated"*), to demonstrate that the PPI group were able to develop a refined typology of the consultations which challenged the assumptions of the project team, as well as their own views. The group were discussing how to code a particular consultation where a diabetologist used a patient\'s agenda form to frame the consultation:PPI4I got it when \[consultant\] said about the two agendas merging, I got that bit. If I was the patient I would think I would be happy‐ish to hear that, you know, at least we\'re going the right way. PPI3Who *cares* about \[consultant\'s\] agenda, I\'m here with *my* agenda! I\'ve just worked on, brought it in, I don\'t really care what his agenda is \[laughs\] I want my issues dealt with, you know. I mean, if somebody said that to me: well, whoopee do for you! Have I got what I want? (Extract 5)

PPI3 was emphatic that "her agenda" should always be prioritized over that of the diabetologist. The discussion continued, as to when it would be appropriate for a diabetologist to question the patient\'s agenda:PPI3I did wonder why the \[consultant\] didn\'t probe more into why the patient didn\'t want four injections a day... RYou could also interpret that positively...if the patient has stated a preference they would like it to be that way, it\'s not up to me to question that, it\'s up to me to discuss whether we can actually... PPI3I don\'t think I agree with that at all...there\'s such an issue here about, you know, blood sugar control is so important for all the other things including cardiovascular disease. (Extract 6)

Despite wanting her agenda to be *enacted*, PPI3 thought it remiss of the diabetologist not to challenge the patient\'s underlying assumptions:PPI3I think if you\'re going to be a good physician, then you have to recognise when you need to step in regardless of the patient\'s agenda and I think it\'s very good that he acknowledges the patient\'s agenda and he\'s following the patient\'s agenda but on this point I think that he needs to explore it more with a view to giving this man the best possible treatment he can have... But definitely I think, you know, that may be on his agenda, but sometimes I think that they --- the consultant should be overriding it with as much negotiation as is possible. RSo you said if I go I don\'t care about the consultant\'s agenda, it\'s my agenda. PPI3Yes. RWhat you\'ve just been saying, actually, the consultant should override the patient\'s agenda if... PPI3Only in that situation...I don\'t think, I can\'t think of another scenario. (Extract 7)

In this way, the group collectively challenged each other about assumed rules for consultation participation and caveats for the use of an agenda, and were able to move from a typology of patients and professionals, to scenarios when a patient\'s agenda may or may not be appropriate.[39](#hex12814-bib-0039){ref-type="ref"} This particular thread developed into a discussion of whether a diabetologist should prioritize health concerns over a patient\'s desire for quality of life, and PPI2 shared his experience of multimorbidity and polypharmacy:PPI2I balance it --- I really want a better quality of life. At the moment I\'m not getting it and my main thing is... it\'s like the morning medication: fifteen tablets that I take and I can\'t eat anything for at least an hour and a half because I feel sick, you know, and that\'s not a good quality of life. RSo would you want more‐ a kind of explicit discussion about the quality of life that maybe if you took fewer medicines or if it was changed whether that might bring increased risks, you know, because in a way, that would be up to you. What kind of a balance would you want between quality of life and risks of things getting worse? PPI2I think, yeah, I would like that sort of discussion, yeah... (Extract 8)

The group members questioned PPI2 about his medication and he conceded that he valued his consultant being directive:PPI2My consultant... said to me...if we don\'t do something you won\'t be here in twelve months, you know, so it was drastic for me.... The drugs I\'m on, and I\'ve been on them so long, it\'s, you know, the damage is already done, you know. I may probably have a limited amount of life left but I know what I can do and how long, do you know what I mean? I know my limitations. I don\'t think this guy knows his limitations. (Extract 9)

After PPI2 was so open about his own experience, PPI3 revised her own position again:PPI2Actually I\'m just going to confound all of my arguments...With PPI3 talking I\'ve just remembered something about quality of life over health care, and at one point my consultant and I agreed that if I had any more insulin I would put on more weight, I would develop more insulin resistance and blood sugars would go up and go up. So we actually agreed, despite the fact that my HbA1c was quite high, that having more insulin at that point was just going to make all of my problems worse. But then, looking at it back down the line, that\'s probably why I\'ve got retinopathy, you know. I\'ve lost a lot of my sight on the periphery, can\'t drive at night... (Extract 10)

This account demonstrates the importance of trust and continuity between patients and providers and the importance of continuity of care; but also the importance of trust and continuity within the PPI group, such that difficult conversations could be surfaced, tensions explored, and misunderstandings or assumptions resolved. The contrasting and complementing views of the PPI group acted as a brake on any assumption that the researchers might have made about the patient\'s agenda always having primacy, and the quality of their argument augmented knowledge about the contexts in which an agenda form may or may not be useful.

3.3. Workshop 3: Re‐challenge {#hex12814-sec-0015}
-----------------------------

In the final workshop, members of the PPI group demonstrated their ability to analyse and synthesize the findings from the qualitative data. This illustration depicts the confidence with which they could apply their understanding (or analytical framework) to vignettes produced from additional consultations and interviews:PPI6Well we\'ve got a 42 year old diabetic Type 1 who would appear to have been visiting a diabetic consultant and wasn\'t very excited about being there, answered all the questions negatively, didn\'t commit anything that he wanted to improve and out of nowhere the consultant said about changing the insulin regime but didn\'t quantify it, and then he said 'Oh, I\'ll quite happily do that because of me brother.' So there\'s a note in there which he never picked up on 'Why, what\'s wrong with your brother?' and he\'d just died, he was a diabetic and he\'d died of some cardiac problem. Er, and at the end of it, you know, it was just another meeting he\'s been to out of his 84 over 42 years that didn\'t go anywhere. And, you know, he\'s going through the motions for them... Yes, it\'s *consultant led*, you can identify that from the script here to point to consultant led, yes, there are still, um, the *agenda unvoiced*, yes, there\'s a limit in there. (Extract 11)

Members of the PPI group were given a further opportunity to amend the analytical typology, and it was concluded that the data fitted the categories earlier identified by the PPI representatives. Finally, the group were able to produce a highly nuanced synthetic account of best practice (and new knowledge):RWhat\'s good practice here? PPI4I think it should depend on the patient and, to me, it should be ‐ appear in different \[analytical\] boxes with different patients, 'cause everybody\'s not the same. And everybody won\'t be able to initiating it, you know, some might just be going in and waiting for the doctor to actually start it off and ask them the questions like we did with one of them. PPI2And based purely on that individual, an individual patient. PPI3I suppose in an ideal world, with the same consultant, different patients; you would hope to see the columns populated differently. (Extract 13)

In this final example, the PPI group identified that diabetes consultations required care that was tailored to the needs of the patient and contextual, suggesting that an agenda form was helpful in some situations but not others---a potential challenge to the premise of the feasibility study. Thus, the PPI contribution and wider analysis of the DIAT feasibility study suggested that the study protocol would need further development before a definitive randomized controlled trial would be warranted. By equipping the PPI group with analytical techniques, they were able to engage with the data and crucially, in this clinical trial of a patient‐centred intervention, make the findings clinically relevant.

4. DISCUSSION {#hex12814-sec-0016}
=============

There have been calls both to standardize the practice of involving participants in clinical trials[40](#hex12814-bib-0040){ref-type="ref"} and the reporting of involvement in qualitative analyses.[41](#hex12814-bib-0041){ref-type="ref"} We have responded by demonstrating the process which was undertaken by the PPI group, facilitated by experienced qualitative researchers (JF and NB) and skilled PPI facilitation (AG). By applying our in‐depth knowledge of qualitative research theory and PPI practices, we were able to improve the inclusivity and understanding of this PPI group,[42](#hex12814-bib-0042){ref-type="ref"} by developing an approach more akin to the emancipatory and participatory practices described in the sociological literature.[14](#hex12814-bib-0014){ref-type="ref"}, [15](#hex12814-bib-0015){ref-type="ref"}, [16](#hex12814-bib-0016){ref-type="ref"}

To facilitate catalytic validity, defined as the degree to which research moves those it studies to enable them to better understand the world and transform it,[19](#hex12814-bib-0019){ref-type="ref"} the academic researchers reflected on their own practices and attempted to foster mutually beneficial and non‐paternalistic partnerships with members of the PPI group.[18](#hex12814-bib-0018){ref-type="ref"} This required the deconstruction of established qualitative practices, to enable the PPI representatives to participate in the interpretation of data and knowledge production. This experience led us to reflect that the emancipatory or ethical imperative of PPI is not at odds with the scientific methods employed in clinical trials (of testing and refining hypotheses).

In trying to understand and conceptualize the process described above, both for ourselves and others, we came to the conclusion that what had taken place could be best understood as a dialectical interaction made possible by the creation of a knowledge space where people with differing social relationships to the research process,.that is patients and academics could, nevertheless, interact. In health care, professionals are in possession of a particular form of cultural capital (accumulated knowledge, skills and behaviours) based on their qualifications, and similar privilege applies for health services researchers in the arena of research.[5](#hex12814-bib-0005){ref-type="ref"} Previous research has identified how non‐research--based professionals can feel isolated by the process of having specific tasks within a trial, which can inhibit their sense of agency.[43](#hex12814-bib-0043){ref-type="ref"} Clinicians have suggested that lack of time allowed by planned research activities has limited their ability to adequately recruit patients to clinical trial targets,[44](#hex12814-bib-0044){ref-type="ref"}, [45](#hex12814-bib-0045){ref-type="ref"} while others have detailed the emotional labour of managing patients' (mis)understanding of randomization processes.[46](#hex12814-bib-0046){ref-type="ref"} Even though the PPI activities in this study were crafted to achieve longitudinal inclusion, this did not mitigate the partial view of the research that PPI collaborators expressed early in the research process. We thus considered the experience as akin to the boundaries of inclusion described by some clinicians participating in trials. However, by making changes to our usual research practices, the contribution to QDA specifically was perceived by PPI collaborators was a particularly valuable experience, because it went some way towards valuing their knowledge and redistributing power, which enabled them as "knowledgeable actors" within a knowledge space.[5](#hex12814-bib-0005){ref-type="ref"} In turn, this enabled us to develop a far more nuanced understanding of diabetology consultations and identify the limitations of our intervention within current health‐care provision.[27](#hex12814-bib-0027){ref-type="ref"}, [28](#hex12814-bib-0028){ref-type="ref"}

In 1808, Fichte[47](#hex12814-bib-0047){ref-type="ref"} identified that forming a thesis involves setting out or laying down an argument. The thesis is then challenged by its antithesis. This challenge is then itself challenged, and a process of reconciliation is sought in a synthesis where both views are accommodated or surpassed. In an ongoing process, this synthesis becomes the starting point for a new cycle of knowledge creation.[48](#hex12814-bib-0048){ref-type="ref"} For Fichte, this process was not the preserve of academics, but rather antithesis was the process by which others held the elite in check.[49](#hex12814-bib-0049){ref-type="ref"} In 1940, Popper[50](#hex12814-bib-0050){ref-type="ref"} contended that this dialectic triad (of thesis, antithesis and synthesis) surpassed the traditional scientific method of trial and error, as it contained an imperative to reconcile or further explore different perspectives, which were absent from other methods of scientific enquiry.

A *thesis* is formed when an idea or *hypothesis* is outlined, and we began our analytical process by orientating the PPI group to our preliminary typology in response to the overall research question which the pilot trial sought to answer. The PPI group subsequently developed the preliminary typology by proposing their own terms. An *antithesis* is the *challenge* to a thesis by the presentation of contrasting or opposing views, and as the PPI group discussed the data with each other, they began to challenge the researchers', each other\'s, and indeed their own interpretations. With such a wealth of experience, we did not expect the PPI group to have a unified voice, and here, we demonstrate how they wove individual stories into storylines which, as qualitative researchers, we typically think of as "themes." A *synthesis* occurs when the *challenge produced by an antithesis is itself challenged*. It becomes the next thesis to inform the analytical process, which the PPI group engaged with by testing out their own hypotheses. In the final analysis workshop, members of the group demonstrated their ability to analyse and synthesize the findings from the qualitative data. This approach may have utility in other areas of health services research, and clinical trials more specifically, for example when assumptions about the acceptability or effectiveness of trial interventions warrants further exploration to identify core components and their optimal alignment.[29](#hex12814-bib-0029){ref-type="ref"}

By detailing our approach, we are able to suggest a template for how other researchers might facilitate PPI in QDA (Table [2](#hex12814-tbl-0002){ref-type="table"}). We are aware that this is one illustrative example of a broader dialectical process. Here, the PPI group was provided with a typology to initiate the dialectical process, although this initial "thesis" could have been generated by patients, with academics providing the "antithesis." Similarly, the dialectic process could have continued, but we were constrained by the timeframe of the funded project.

###### 

Template for PPI involvement in QDA

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Objectives                                                                                            Activities
  ----------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Overall objective:\                                                                                   Establish nature of involvement.\
  For PPI representatives to make a contribution to QDA                                                 Recruitment from a range of organizations.\
                                                                                                        Study orientation: Familiarization with aims and objectives.Introduction to wider team members.Ongoing jargon busting.\
                                                                                                        Attendance at team/steering meetings

  To learn from the experiences of PPI collaborators and make any necessary modifications to practice   Completion of PPI dairies and initial interviews, to identify barriers and facilitators to participation, and experience more generally

  To improve researcher understanding                                                                   Facilitate PPI input into: (as appropriate) Study documentation, including recruitment materials, letters to potential participants, lay summaries.Intervention developmentStaff training.Qualitative topic guide.

  To provide stimulus for analytical discussions                                                        Provisional coding frame produced by research team members

  For PPI to make a contribution to QDA\                                                                Workshop 1:\
  For QDA to be accessible\                                                                             Training\
  To capture PPI perspectives                                                                           Role‐play of consultations/interviews\
                                                                                                        Provision of vignettes\
                                                                                                        Data collection techniques: audio‐recording, note‐taking, flipchart, emails

  Revision of coding frame as data collection and data analysis develop                                 Revision of coding frame by researcher, (revision of topic guide/research practices could also be revised here)

  For PPI to make a contribution to QDA\                                                                Workshop 2:\
  For QDA to be accessible\                                                                             Role‐play of consultations/interviews\
  To capture PPI perspectives                                                                           Provision of vignettes\
                                                                                                        Data collection techniques: audio‐recording, note‐taking, flipchart, emails

  Revision of coding frame as data collection and data analysis develop                                 Revision of coding frame by researchers

  Finalization of coding frame once all data have been accounted for                                    Workshop 3:\
                                                                                                        Provision of vignettes

  To learn from the experiences of PPI collaborators and plan future revisions to practice              Evaluation:\
                                                                                                        Repeat interviews and revisit diaries\
                                                                                                        Data collection techniques: audio‐recording, note‐taking, flipchart, emails

  To include PPI representatives in the dissemination of the research findings                          PPI co‐authorship on draft papers:\
                                                                                                        PPI input into paper writing and wider dissemination activities
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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A strength of this approach is that it facilitates meaningful patient and public involvement which we feel both augments the validity of the research findings and provides a replicable process that could be employed in other clinical trials or qualitative studies. A limitation might concern the individuals who were engaged in this study. Two members of the research team had diabetes, but we supplemented this involvement with workshops involving a broader group of people. This enabled us to surface tensions between perspectives of different PPI representatives, enabling us to develop a more nuanced understanding of the issues raise which contributed to a shared understanding of the research findings. A further limitation might be the skill and training required by the research team to facilitate PPI in this way,[51](#hex12814-bib-0051){ref-type="ref"}, [52](#hex12814-bib-0052){ref-type="ref"} which may be perceived as burdensome. This requires an understanding of the principles, practices and possibilities afforded by the various qualitative methodologies, as well as openness to the challenges of translating the theory and practice of research in order to make it accessible and participatory,[53](#hex12814-bib-0053){ref-type="ref"}, [54](#hex12814-bib-0054){ref-type="ref"} rather than as a quick‐fix or tickbox approach.

5. CONCLUSION {#hex12814-sec-0017}
=============

We successfully trained and collaborated with PPI representatives to undertake qualitative data analysis which transformed our understanding of doctor--patient consultations,[24](#hex12814-bib-0024){ref-type="ref"} and the appropriate uses of an agenda form. This required changes to our usual research practices, in terms of purposively constructing a knowledge space to break down lay and professional boundaries; but was in keeping with the objective of establishing meaningful patient involvement for a definitive trial. We propose that our knowledge production process of thesis, antithesis and synthesis can be used as a template for other researchers who work on clinical trials or health services research more generally. Furthermore, we suggest that researchers should document and analyse the nature of the interpretation itself.

We contend that the driver for actively involving patients and members of the public in clinical trials should not merely be its requirement for successful funding.[38](#hex12814-bib-0038){ref-type="ref"} Rather, the imperative should be to develop more holistic understandings of complex problems via a change in the way that knowledge is produced,[48](#hex12814-bib-0048){ref-type="ref"} Dingwall et al[47](#hex12814-bib-0047){ref-type="ref"} proposed that qualitative research can augment the findings of clinical trials and address the humanitarian issues of equity and effectiveness. We propose that by undertaking QDA with PPI representatives using a dialectic process, we collectively produced more valid and clinically relevant findings.
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